First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC).

Authors :: Mercinelli, Chiara
Basile, Giuseppe
Raggi, Daniele
Cigliola, Antonio
Tateo, Valentina
Patanè, Damiano Alfio
Crupi, Emanuele
Padua, Tiago Costa de
Colecchia, Maurizio
Colombo, Renzo
Moschini, Marco
Re, Chiara
Avesani, Giulio
Brembilla, Giorgio
De Cobelli, Francesco
Briganti, Alberto
Pavlick, Dean C.
Ross, Jeffrey S.
Montorsi, Francesco
Necchi, Andrea
Source :: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p610-610, 193p
Publication Year :: 2024

Full Text Access

Tools